Compile Data Set for Download or QSAR
maximum 50k data
Found 65 Enz. Inhib. hit(s) with all data for entry = 10724
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562152(N-Methyl-1-(2-oxo-3,4-dihydro-1H-quinolin-6-yl)-2-...)
Affinity DataKd:  27nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562153(2-[2-(Hydroxymethyl)-4-pyridyl]-N-methyl-1-(2-oxo-...)
Affinity DataKd:  14nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562155(2-[[2-Methoxy-4-(trifluoromethyl)phenyl]methyl]-N-...)
Affinity DataKd:  17nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562156(2-(2-Acetyl-3-pyridyl)-N-methyl-1-(2-oxo-3,4-dihyd...)
Affinity DataKd:  4nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562157(N-Methyl-2-[3-(methylcarbamoyl)-2-pyridyl]-1-(2-ox...)
Affinity DataKd:  2nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562158(Methyl 2-isopropyl-1-(6-oxo-7,8-dihydro-5H-1,5-nap...)
Affinity DataKd:  20nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562159(2-Isopropyl-N-methyl-1-(6-oxo-7,8-dihydro-5H-1,5-n...)
Affinity DataKd:  11nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562160(2-Isopropyl-N,N-dimethyl-1-(6-oxo-7,8-dihydro-5H-1...)
Affinity DataKd:  22nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562161(7-(1H-Imidazol-1-yl)-3,4-dihydroquinolin-2(1H)-one...)
Affinity DataKd:  16nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562162(6-(Indoline-1-carbonyl)-3,4-dihydro-1H-quinolin-2-...)
Affinity DataKd:  232nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562163(6-(2,3-Dihydropyrrolo[2,3-b]pyridine-1-carbonyl)-3...)
Affinity DataKd:  23nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562164(6-(3,4-Dihydro-2H-quinoline-1-carbonyl)-3,4-dihydr...)
Affinity DataKd:  5nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562165(N-(1-Acetyl-4-piperidyl)-2-oxo-3,4-dihydro-1H-quin...)
Affinity DataKd:  41nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562166(6-(Indoline-1-carbonyl)-3,4-dihydro-1H-1,8-naphthy...)
Affinity DataKd:  62nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562167(6-(2,3-Dihydropyrrolo[2,3-b]pyridine-1-carbonyl)-3...)
Affinity DataKd:  3nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562168(6-(3,4-Dihydro-2H-quinoline-1-carbonyl)-3,4-dihydr...)
Affinity DataKd:  1nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562169(6-(2-Isopropyl-1H-benzo[d]imidazol-1-yl)-3,4-dihyd...)
Affinity DataKd:  171nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562170(2-Isopropyl-N-methyl-1-(2-oxo-1,2,3,4-tetrahydroqu...)
Affinity DataKd:  120nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562171(N-(10-(2-((6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-...)
Affinity DataKd:  338nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562172(N-(5-(2-((6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6...)
Affinity DataKd:  258nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562173(N-(2-(2-(2-(2-((6S)-4-(4-Chlorophenyl)-2,3,9-trime...)
Affinity DataKd:  524nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM50000309(6-Imidazol-1-yl-3,4-dihydro-1H-quinolin-2-one | CH...)
Affinity DataKd:  416nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562109(N-Methyl-2-[2-(3-methylimidazol-4-yl)-4-quinolyl]-...)
Affinity DataKd:  40nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562110(2-Ethyl-N-methyl-1-(2-oxo-3,4-dihydro-1H-quinolin-...)
Affinity DataKd:  190nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562111(N-Methyl-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)...)
Affinity DataKd:  49nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562112(3-(1-Methyl-1H-imidazol-5-yl)-N-(2-oxo-1,2,3,4-tet...)
Affinity DataKd:  677nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562113(2-Benzyl-N-methyl-1-(2-oxo-1,2,3,4-tetrahydroquino...)
Affinity DataKd:  702nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562114(2-Cyclopropyl-N-methyl-1-(2-oxo-1,2,3,4-tetrahydro...)
Affinity DataKd:  456nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562115(2-((Benzyloxy)methyl)-N-methyl-1-(2-oxo-1,2,3,4-te...)
Affinity DataKd:  788nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562116(6-(1H-Imidazol-1-yl)-3,4-dihydro-1,8-naphthyridin-...)
Affinity DataKd:  16nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562117(2-(2-Methoxybenzyl)-N-methyl-1-(2-oxo-1,2,3,4-tetr...)
Affinity DataKd:  10nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562118(N-Methyl-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)...)
Affinity DataKd:  616nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562119(N-Methyl-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)...)
Affinity DataKd:  250nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562120(2-(2-Methoxypyridin-4-yl)-N-methyl-1-(2-oxo-1,2,3,...)
Affinity DataKd:  31nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562121(6-(5-Phenyl-1H-imidazol-1-yl)-3,4-dihydroquinolin-...)
Affinity DataKd:  9nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562122(2-(Hydroxymethyl)-N-methyl-1-(2-oxo-1,2,3,4-tetrah...)
Affinity DataKd:  11nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562123(2-(2-(Cyclopropanecarboxamido)ethyl)-N-methyl-1-(2...)
Affinity DataKd:  27nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562124(Ethyl 5-(methylcarbamoyl)-1-(2-oxo-1,2,3,4-tetrahy...)
Affinity DataKd:  10nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562125(2-(2-Aminoethyl)-N-methyl-1-(2-oxo-1,2,3,4-tetrahy...)
Affinity DataKd:  4nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562126(Methyl 4-((2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)a...)
Affinity DataKd:  30nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562127(N-Methyl-2-(morpholine-4-carbonyl)-1-(2-oxo-1,2,3,...)
Affinity DataKd:  10nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562128((RS)—N-(7-Oxo-5,6,7,8-tetrahydro-1,8-naphthyr...)
Affinity DataKd:  4nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562129(Methyl 2-(2-methoxypyridin-4-yl)-1-(2-oxo-1,2,3,4-...)
Affinity DataKd:  4nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562130(2-(6-Methoxypyridin-2-yl)-N-methyl-1-(2-oxo-1,2,3,...)
Affinity DataKd:  15nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562131(2-(6-Methoxypyridin-3-yl)-N-methyl-1-(2-oxo-1,2,3,...)
Affinity DataKd:  12nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562132(2-(4-Methoxypyridin-2-yl)-N-methyl-1-(2-oxo-1,2,3,...)
Affinity DataKd:  3nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562133(2-(2-Methoxypyridin-3-yl)-N-methyl-1-(2-oxo-1,2,3,...)
Affinity DataKd:  15nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562134(6-(5-(4-Methoxyphenyl)-1H-imidazol-1-yl)-3,4-dihyd...)
Affinity DataKd:  22nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562135(2-Isopropyl-N-methyl-1-(7-oxo-6,8-dihydro-5H-1,8-n...)
Affinity DataKd:  8nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProtein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM562136(2-(2-Methoxy-4-pyridyl)-N-methyl-1-(7-oxo-6,8-dihy...)
Affinity DataKd:  35nMAssay Description:Process 1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content 2) Titrati...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 65 total ) | Next | Last >>
Jump to: